LifeSeasons to Conduct Clinical Studies on its Products
LifeSeasons (Lewisville, TX) has announced that it is taking its clinical research initiatives and commitment to science to a new level. The company will be conducting clinical studies to support the efficacy of its products over the next year and beyond. Gathering more product-specific clinical research data will be a significant focus for the company moving forward.
“LifeSeasons supplements are formulated using scientifically proven and potent ingredients, but with consumers increasingly seeking transparency and clinical research results, we are stepping up our efforts to provide proprietary scientific support,” said Darrin Peterson, founder and CEO of LifeSeasons. “These investigative studies will allow us to build greater trust with our consumers, as well as provide them with proven and safe alternatives to pharma-based health products.”
Inspired to expand its mission, LifeSeasons began clinical research activity last year in the country of Grenada, located in Southeastern Caribbean. The company plans to conduct additional studies in the near future on its newest and best-selling products including Anxie-T, a stress support supplement, Neuro-T, a brain focus support supplement, Choles-T, a cholesterol support supplement, and Glucose Stabili-T, a blood sugar management supplement.
Currently, a clinical study is taking place in Grenada on LifeSeasons Glucose Stabili-T product. Grenada has a population, which is documented to have a high-risk diagnosis of metabolic syndrome. LifeSeasons partnered with both the Windward Islands Research and Education Foundation (WINDREF), a non-profit organization that promotes health and well being through research and education, as well as the Ministry of Health in Grenada. Together, they are conducting the first-ever triple-blind placebo-controlled study investigating the efficacy of LifeSeasons blood sugar support supplement Glucose Stabili-T.
“The small island of Grenada has struggled to combat diabetes, and it has taken a major toll on this independent island country,” said Jamie Langston, chief research officer at LifeSeasons. “We are looking forward to the results of this study later this year, and are thrilled to enter this partnership to benefit the population of Grenada.”
For more information, visit www.lifeseasons.com.
